HUP0202880A2 - Nyújtott felszabadulású készítmények, eljárás előállításukra és alkalmazásuk - Google Patents
Nyújtott felszabadulású készítmények, eljárás előállításukra és alkalmazásukInfo
- Publication number
- HUP0202880A2 HUP0202880A2 HU0202880A HUP0202880A HUP0202880A2 HU P0202880 A2 HUP0202880 A2 HU P0202880A2 HU 0202880 A HU0202880 A HU 0202880A HU P0202880 A HUP0202880 A HU P0202880A HU P0202880 A2 HUP0202880 A2 HU P0202880A2
- Authority
- HU
- Hungary
- Prior art keywords
- salt
- lactic acid
- producing
- same
- sustained release
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- 238000013268 sustained release Methods 0.000 title 1
- 239000012730 sustained-release form Substances 0.000 title 1
- XBBVURRQGJPTHH-UHFFFAOYSA-N 2-hydroxyacetic acid;2-hydroxypropanoic acid Chemical compound OCC(O)=O.CC(O)C(O)=O XBBVURRQGJPTHH-UHFFFAOYSA-N 0.000 abstract 3
- 229920000642 polymer Polymers 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical class C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 239000003405 delayed action preparation Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000013265 extended release Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Biological Depolymerization Polymers (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Polyesters Or Polycarbonates (AREA)
Abstract
A találmány nyújtott felszabadulású készítményre vonatkozik, amely egygyógyászatilag hatásos anyagot vagy sóját, egy hidroxinaftoesav-származékot vagy sóját és egy tejsav-glikolsav-polimert vagy sójáttartalmazza, amely termékben a tejsav-glikolsav-polimer tömeg szerintiközepes molekulatömege a tejsav-glikolsav-polimer tömegegységére (g)számított terminális karboxilcsoportjainak mennyiségére (pmol)vonatkoztatva 1 200 000 és 3 000 000 közötti (a határok beleértendők).A találmány kiterjed ezek előállítására, és az ilyen nyújtottfelszabadulású készítményt tartalmazó gyógyszerekre is. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20188799 | 1999-07-15 | ||
PCT/JP2000/004683 WO2001005380A1 (fr) | 1999-07-15 | 2000-07-13 | Compositions a liberation lente, techniques de production et methodes d'utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0202880A2 true HUP0202880A2 (hu) | 2003-01-28 |
HUP0202880A3 HUP0202880A3 (en) | 2003-04-28 |
Family
ID=16448493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0202880A HUP0202880A3 (en) | 1999-07-15 | 2000-07-13 | Sustained release compositions, process for producing the same and use thereof |
Country Status (21)
Country | Link |
---|---|
US (2) | US7265157B1 (hu) |
EP (1) | EP1197208B1 (hu) |
KR (1) | KR20020012312A (hu) |
CN (1) | CN1361685A (hu) |
AT (1) | ATE360413T1 (hu) |
AU (1) | AU5853000A (hu) |
BR (1) | BR0012400A (hu) |
CA (1) | CA2378714A1 (hu) |
CZ (1) | CZ2002114A3 (hu) |
DE (1) | DE60034568T2 (hu) |
HK (1) | HK1042237A1 (hu) |
HU (1) | HUP0202880A3 (hu) |
IL (1) | IL147417A0 (hu) |
MX (1) | MXPA02000461A (hu) |
NO (1) | NO20020084L (hu) |
NZ (1) | NZ516466A (hu) |
PL (1) | PL352499A1 (hu) |
RU (1) | RU2002103718A (hu) |
SK (1) | SK342002A3 (hu) |
WO (1) | WO2001005380A1 (hu) |
ZA (1) | ZA200200347B (hu) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2230550C2 (ru) | 1998-01-16 | 2004-06-20 | Такеда Кемикал Индастриз, Лтд. | Композиции длительного высвобождения, способ их получения и применение |
CA2355186C (en) * | 1998-12-15 | 2008-03-18 | Takeda Chemical Industries, Ltd. | Process for producing polymer |
JP5046447B2 (ja) | 2000-08-07 | 2012-10-10 | 和光純薬工業株式会社 | 乳酸重合体及びその製造方法 |
EP1374855A1 (en) * | 2001-03-30 | 2004-01-02 | Takeda Chemical Industries, Ltd. | Medicinal solutions |
EP1382350A4 (en) * | 2001-04-25 | 2006-01-04 | Takeda Pharmaceutical | MEANS AGAINST THE PROPHYLAXIS BEFORE POSTOPERATIVE REPEAT OF PREMOPEOPAUSAL BREAST CANCER |
US6693134B2 (en) | 2001-05-29 | 2004-02-17 | Chemokine Therapeutics Corporation | Bicyclic aromatic chemokine receptor ligands |
AR034641A1 (es) * | 2001-06-29 | 2004-03-03 | Takeda Pharmaceutical | Composicion de liberacion controlada y metodo para producirla |
WO2003055470A1 (fr) * | 2001-12-26 | 2003-07-10 | Takeda Chemical Industries, Ltd. | Nouvelle microsphere et son procede de production |
US8088726B2 (en) | 2002-06-25 | 2012-01-03 | Takeda Pharmaceutical Company Limited | Process for producing sustained-release composition |
WO2005009357A2 (en) * | 2003-07-23 | 2005-02-03 | Pr Pharmaceuticals, Inc. | Controlled release compositions |
US20050064045A1 (en) * | 2003-09-18 | 2005-03-24 | Sheng-Ping Zhong | Injectable therapeutic formulations |
US7906125B2 (en) | 2003-09-18 | 2011-03-15 | Boston Scientific Scimed, Inc. | Solid or semi-solid therapeutic formulations |
TW200529890A (en) | 2004-02-10 | 2005-09-16 | Takeda Pharmaceutical | Sustained-release preparations |
EP1679065A1 (en) | 2005-01-07 | 2006-07-12 | OctoPlus Sciences B.V. | Controlled release compositions for interferon based on PEGT/PBT block copolymers |
US7862552B2 (en) | 2005-05-09 | 2011-01-04 | Boston Scientific Scimed, Inc. | Medical devices for treating urological and uterine conditions |
US8263109B2 (en) | 2005-05-09 | 2012-09-11 | Boston Scientific Scimed, Inc. | Injectable bulking compositions |
JP2009523122A (ja) * | 2005-12-13 | 2009-06-18 | ハルクネスス プハルマセウティカルス,インコーポレイテッド | エンテロスタチンを使用して肥満を治療する方法 |
US20070149457A1 (en) * | 2005-12-13 | 2007-06-28 | Byron Rubin | Stable solid forms of enterostatin |
WO2008008357A1 (en) * | 2006-07-11 | 2008-01-17 | Harkness Pharmaceuticals, Inc. | Methods of treating obesity using satiety factors |
US7858663B1 (en) * | 2007-10-31 | 2010-12-28 | Pisgah Laboratories, Inc. | Physical and chemical properties of thyroid hormone organic acid addition salts |
TWI481424B (zh) | 2006-12-18 | 2015-04-21 | Takeda Pharmaceutical | 緩釋性組成物及其製法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996022786A1 (en) | 1995-01-23 | 1996-08-01 | Takeda Chemical Industries, Ltd. | Sustained-release preparation and use |
DK0839525T3 (da) | 1996-10-31 | 2004-11-29 | Takeda Pharmaceutical | Præparat med forlænget frigivelse |
WO1998032423A1 (en) * | 1997-01-29 | 1998-07-30 | Takeda Chemical Industries, Ltd. | Sustained-release microspheres, their production and use |
RU2230550C2 (ru) | 1998-01-16 | 2004-06-20 | Такеда Кемикал Индастриз, Лтд. | Композиции длительного высвобождения, способ их получения и применение |
JPH11269094A (ja) * | 1998-01-16 | 1999-10-05 | Takeda Chem Ind Ltd | 徐放性組成物、その製造法および用途 |
CA2355186C (en) | 1998-12-15 | 2008-03-18 | Takeda Chemical Industries, Ltd. | Process for producing polymer |
-
2000
- 2000-07-13 SK SK34-2002A patent/SK342002A3/sk not_active Application Discontinuation
- 2000-07-13 MX MXPA02000461A patent/MXPA02000461A/es not_active Application Discontinuation
- 2000-07-13 RU RU2002103718/14A patent/RU2002103718A/ru not_active Application Discontinuation
- 2000-07-13 US US10/019,786 patent/US7265157B1/en not_active Expired - Fee Related
- 2000-07-13 CA CA002378714A patent/CA2378714A1/en not_active Abandoned
- 2000-07-13 BR BR0012400-1A patent/BR0012400A/pt not_active IP Right Cessation
- 2000-07-13 AU AU58530/00A patent/AU5853000A/en not_active Abandoned
- 2000-07-13 HU HU0202880A patent/HUP0202880A3/hu unknown
- 2000-07-13 CN CN00810405A patent/CN1361685A/zh active Pending
- 2000-07-13 EP EP00944418A patent/EP1197208B1/en not_active Expired - Lifetime
- 2000-07-13 NZ NZ516466A patent/NZ516466A/xx unknown
- 2000-07-13 AT AT00944418T patent/ATE360413T1/de not_active IP Right Cessation
- 2000-07-13 KR KR1020027000546A patent/KR20020012312A/ko not_active Application Discontinuation
- 2000-07-13 DE DE60034568T patent/DE60034568T2/de not_active Expired - Fee Related
- 2000-07-13 IL IL14741700A patent/IL147417A0/xx unknown
- 2000-07-13 PL PL00352499A patent/PL352499A1/xx not_active Application Discontinuation
- 2000-07-13 CZ CZ2002114A patent/CZ2002114A3/cs unknown
- 2000-07-13 WO PCT/JP2000/004683 patent/WO2001005380A1/ja active IP Right Grant
-
2002
- 2002-01-08 NO NO20020084A patent/NO20020084L/no not_active Application Discontinuation
- 2002-01-15 ZA ZA200200347A patent/ZA200200347B/en unknown
- 2002-05-11 HK HK02103567.5A patent/HK1042237A1/zh unknown
-
2007
- 2007-07-25 US US11/782,707 patent/US20080014237A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1197208B1 (en) | 2007-04-25 |
PL352499A1 (en) | 2003-08-25 |
KR20020012312A (ko) | 2002-02-15 |
NO20020084L (no) | 2002-03-14 |
US7265157B1 (en) | 2007-09-04 |
BR0012400A (pt) | 2002-05-21 |
MXPA02000461A (es) | 2002-07-30 |
SK342002A3 (en) | 2002-05-09 |
RU2002103718A (ru) | 2003-10-10 |
WO2001005380A1 (fr) | 2001-01-25 |
CN1361685A (zh) | 2002-07-31 |
CA2378714A1 (en) | 2001-01-25 |
EP1197208A4 (en) | 2004-06-30 |
HUP0202880A3 (en) | 2003-04-28 |
US20080014237A1 (en) | 2008-01-17 |
HK1042237A1 (zh) | 2002-08-09 |
NZ516466A (en) | 2003-02-28 |
ATE360413T1 (de) | 2007-05-15 |
AU5853000A (en) | 2001-02-05 |
EP1197208A1 (en) | 2002-04-17 |
DE60034568D1 (de) | 2007-06-06 |
CZ2002114A3 (cs) | 2002-04-17 |
NO20020084D0 (no) | 2002-01-08 |
ZA200200347B (en) | 2003-03-26 |
DE60034568T2 (de) | 2008-01-03 |
IL147417A0 (en) | 2002-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0202880A2 (hu) | Nyújtott felszabadulású készítmények, eljárás előállításukra és alkalmazásuk | |
HUP0203821A2 (hu) | Új oligoszacharidok, előállításuk és ezeket tartalmazó gyógyszerkészítmények | |
HUP0100221A2 (hu) | Nyújtott hatású készítmény és eljárás az előállítására, valamint alkalmazása | |
HUP0203257A2 (hu) | Atorvastatin kalcium polimorf módosulatai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
CA2234610A1 (en) | New amino acid derivatives, processes for preparing them and pharmaceutical compositions containing these compounds | |
HUP0400382A2 (hu) | Késleltetett leadású készítmény és eljárás annak előállítására | |
MD1233C2 (ro) | Derivaţi de eritromicină, procedeu de preparare a lor şi compoziţie farmaceutică pe baza acestora | |
CA2339290A1 (en) | Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions | |
HUP9802999A2 (hu) | N-propargil-1-amino-indánt tartalmazó gyógyszerkészítmény | |
HUP0102579A2 (hu) | Antiangiogén hatású peptid gyógyszervegyületek, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP0101411A2 (hu) | 2-es típusú angiotenzin II receptor agonistákat tartalmazó gyógyszerkészítmények és ezek alkalmazása | |
PT1086124E (pt) | Ciclosporinas novas | |
HUP0104762A2 (hu) | Moxifloxacin-tartalmú gyógyászati készítmények és eljárás az előállításukra | |
HUP0402492A2 (hu) | 5HT4 részleges agonistát tartalmazó gyógyszerkészítmények | |
HUP0301817A2 (hu) | Kahalalid-vegyületek, elżállításukra szolgáló eljárás, azokat tartalmazó gyógyászati készítmények és alkalmazásuk | |
HUP0200580A2 (hu) | Celecoxib polimorf kristályos formái, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
PL346143A1 (en) | Tan-1057 derivatives | |
HUP0004331A2 (hu) | A fankinon (4,7-fenantrolin-5,6-dion alkalmazása az Alzheimer-kór kezelésére szolgáló gyógyszerkészítmények előállítására és ezt tartalmazó kombinált gyógyszerkészítmény | |
HUP0300330A2 (hu) | Oligoszacharidok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP9904327A2 (hu) | Kinupristint és dalfopristint tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
HUP0105359A2 (hu) | Benzamidszármazékok és az azokat tartalmazó gyógyszerkészítmények | |
HUP9904077A2 (hu) | Kristályos gyógyszerészeti termék | |
EP2239270A3 (en) | Low molecular weight peptide derivatives as inhibitors of the Laminin/Nidogen interaction | |
HUP0203270A2 (hu) | Hidroxánsav-származék mint a humán CD23 termelés inhibitora, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények és alkalmazásuk | |
MY129892A (en) | The meglumine salt of a 1,2,3,4-tetrahydro-2-quinoline carboxylic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |